|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Levemir (Insulin Detemir Subcutaneous). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (613)
Cases resulting in a serious event (133)
Cases resulting in death (10)
Cases resulting in life threatening events (17)
Cases resulting in hospitalization (53)
Cases resulting in disability (2)
Cases resulting in other serious reactions (77)
Below is a sample of reports where side effects / adverse reactions may be related to Levemir (Insulin Detemir Subcutaneous). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from United Kingdom on 2007-10-31
Patient: female, weighing 51.0 kg (112.2 pounds)
Adverse reactions / side effects: Head Injury
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Levemir
Dosage: 30 iu, qd
Start date: 2005-10-17
Novorapid
Dosage: 47 iu, qd
Start date: 2005-10-17
Adverse event in receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from United States on 2007-10-31
Patient:
Adverse reactions / side effects: Dyspnoea, Throat Tightness, Rash Pruritic
Adverse event resulted in: hospitalization
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 29 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from Bulgaria on 2007-10-31
Patient: 29 year old female
Adverse reactions / side effects: Intentional Overdose
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Other drugs received by patient: Novorapid
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Injection Site Injury
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 49 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 49 year old female
Adverse reactions / side effects: Device Failure, Injection Site Pain
Suspect drug(s):
Levemir
Dosage: 20 iu, qd, subcutaneous ; 35 iu, qd
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-06-17
End date: 2007-07-01
Levemir
Dosage: 20 iu, qd, subcutaneous ; 35 iu, qd
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-07-01
Adverse event in 61 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 61 year old female
Adverse reactions / side effects: Hypoglycaemic Unconsciousness, Hypoglycaemia, Blood Glucose Increased
Suspect drug(s):
Humalog
Dosage: sliding scale, subcutaneous
Indication: Type 1 Diabetes Mellitus
Levemir
Dosage: see image
Indication: Type 1 Diabetes Mellitus
Start date: 2007-01-09
Novolin N
Dosage: 10 iu, qd, subcutaneous
Indication: Type 1 Diabetes Mellitus
Start date: 2005-07-01
Other drugs received by patient: Lisinopril; Lipitor; Aspirin; Levothyroxine Sodium; Furosemide
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Blood Glucose Decreased, Pain in Extremity
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 63 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Pruritus
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 68 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 68 year old female
Adverse reactions / side effects: Foot Deformity, Musculoskeletal Pain, Muscle Spasms
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Other drugs received by patient: Diovan; Norvasc; Toprol-XL; Glucotrol
Adverse event in 67 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 67 year old male
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir
Dosage: 28 iu, qd, subcutaneous ; 32 iu, qd, subcutaneous
Indication: Type 1 Diabetes Mellitus
Start date: 2007-08-30
End date: 2007-09-01
Levemir
Dosage: 28 iu, qd, subcutaneous ; 32 iu, qd, subcutaneous
Indication: Type 1 Diabetes Mellitus
Start date: 2007-09-01
Adverse event in 62 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 62 year old male
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 80 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 80 year old male
Adverse reactions / side effects: Medication Error, Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 66 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 66 year old female
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus
Novolog
Dosage: subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus
Adverse event in 70 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 70 year old male
Adverse reactions / side effects: Pruritus Generalised, Rash Generalised, Expired Drug Administered
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Other drugs received by patient: Novolog; Aspirin
Adverse event in 64 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 64 year old male
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 71 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 71 year old female
Adverse reactions / side effects: Injection Site Bruising
Suspect drug(s):
Levemir
Dosage: subcutaneous
Indication: Diabetes Mellitus
Start date: 2005-01-01
End date: 2006-01-01
Novolog
Dosage: subcutaneous
Indication: Diabetes Mellitus
Start date: 2005-01-01
End date: 2006-01-01
Adverse event in 63 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 63 year old male
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Other drugs received by patient: Lantus (Insulin Glargine) Suspension FOR Injection
Adverse event in 55 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 55 year old female
Adverse reactions / side effects: Injection Site Bruising
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 75 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from United States on 2007-10-30
Patient: 75 year old female
Adverse reactions / side effects: Injection Site Erythema, Injection Site Pruritus
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 55 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 55 year old female
Adverse reactions / side effects: Diarrhoea, Abdominal Pain Upper
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 67 year old male receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 67 year old male
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in 61 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 61 year old female
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir
Dosage: 88 iu, qd, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus
Novolog
Dosage: 50 iu, qd + sliding scale, subcutaneous
Indication: Insulin-Requiring Type II Diabetes Mellitus
Adverse event in 12 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 12 year old female
Adverse reactions / side effects: Blood Glucose Increased
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Injection Site Injury
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
|
